Cutaneous Oncology News

Almirall announced the FDA accepted a new drug application for tirbanibulin to treat actinic keratosis, according to a press release.

The FDA granted fast track designation to tipifarnib for treatment of adults with one of several types of T-cell lymphoma, according to the agent’s manufacturer.

Self-reported lifetime prevalence of skin cancer was higher in gay and bisexual men compared with heterosexual men, according to a cross-sectional study published in JAMA Dermatology.

Smartphone applications that use algorithms to assess the risk for skin cancer appear to have poor and variable performance, according to a systematic review of diagnostic accuracy studies.

MAUI, HAWAII — New developments in photoprotection should prompt dermatologists to remind patients that photoprotection involves more than just sunscreen, according to a presenter here at Maui Derm for Dermatologists 2020.

MAUI, HAWAII — The FDA decision to study sunscreen ingredients and societies teaming up to develop a guideline for pediatric psoriasis were some of the top updates in dermatology last year, according to presenters here at Maui Derm for Dermatologists 2020.

Educational video modules helped improve dermatology residents’ understanding of Mohs micrographic surgery, according to a research letter published in the Journal of the American Academy of Dermatology.

Six active ingredients in four different commercially-available sunscreen formulations applied by healthy study participants were systemically absorbed through the skin, resulting in exposure levels that exceeded the FDA threshold for safety testing, researchers reported in JAMA.

The Delphi consensus determined that six core outcomes should be reported in regard to actinic keratosis trials, according to a survey study and review published in JAMA Dermatology.

American Cancer Society and Melanoma Research Alliance provided two $1 million grants that will fund research focused on metastasis of melanoma and other cancer types.